Literature DB >> 10931410

Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I.

G Visser1, J P Rake, J Fernandes, P Labrune, J V Leonard, S Moses, K Ullrich, G P Smit.   

Abstract

OBJECTIVE: To investigate the incidence, the severity, and the course of neutropenia, neutrophil dysfunction, and inflammatory bowel disease (IBD) in glycogen storage disease (GSD) type Ib.
METHOD: As part of a collaborative European Study on GSD type I, a retrospective registry was established in 12 European countries that included all patients with GSD-I who were known at the centers and were born from 1960 to 1995. Of a total of 288 patients with GSD-I, 57 who had GSD-Ib form the basis of this study.
RESULTS: Neutropenia (defined as an absolute neutrophil count <1 x 10(9)/L) was found in 54 patients. In 64% of the patients neutropenia was documented before the age of 1 year, but in 18% of the patients neutropenia was first noted between the ages of 6 and 9 years. Neutropenia was persistent in 5 patients and intermittent without any clear cyclical course in 45. Neutrophil function was investigated in 18 patients with neutropenia and was abnormal in all. Perioral infections were reported in 37 patients, perianal infections in 27 patients, and protracted diarrhea in 23 patients. Findings on colonoscopy and radiologic studies in 10 of 20 patients suspected to have IBD were abnormal in all. All patients with IBD, perioral infections, and perianal infections had neutropenia.
CONCLUSIONS: Intermittent severe neutropenia is frequently found in patients with GSD-Ib. The study also indicates that IBD in GSD-Ib is underdiagnosed; up to 77% of the patients studied had evidence of IBD, all of whom had neutropenia. IBD was not detected in those with normal neutrophil counts. These findings support the notion that neutropenia and/or neutrophil dysfunction in GSD-Ib and IBD are causally related.

Entities:  

Mesh:

Year:  2000        PMID: 10931410     DOI: 10.1067/mpd.2000.105232

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  62 in total

Review 1.  Glycogen storage diseases.

Authors:  Joseph I Wolfsdorf; David A Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Allelic heterogeneity of glycogen storage disease type Ib in French patients: a study of 11 cases.

Authors:  P Trioche; F Petit; J Francoual; V Gajdos; L Capel; C Poüs; P Labrune
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 3.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

4.  Mutation spectrum of type I glycogen storage disease in Hungary.

Authors:  G Miltenberger-Miltenyi; L Szonyi; L Balogh; G Utermann; A R Janecke
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 5.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

6.  Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function.

Authors:  Daniela Melis; Fortunata Carbone; Giorgia Minopoli; Claudia La Rocca; Francesco Perna; Veronica De Rosa; Mario Galgani; Generoso Andria; Giancarlo Parenti; Giuseppe Matarese
Journal:  J Immunol       Date:  2017-04-07       Impact factor: 5.422

7.  Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.

Authors:  Saskia B Wortmann; Johan L K Van Hove; Terry G J Derks; Nathalie Chevalier; Vijaya Knight; Andreas Koller; Esmee Oussoren; Johannes A Mayr; Francjan J van Spronsen; Florian B Lagler; Sommer Gaughan; Emile Van Schaftingen; Maria Veiga-da-Cunha
Journal:  Blood       Date:  2020-08-27       Impact factor: 22.113

Review 8.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

Review 9.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

10.  Intestinal function in glycogen storage disease type I.

Authors:  G Visser; J P Rake; F T M Kokke; P G J Nikkels; P J J Sauer; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.